ARV Supply Expected To Stabilise As Court Battle Ends
Monday, November 18, 2019

Bottles of antiretroviral drug
The company had cited irregularities in awarding of a tender for the supply of the drugs, after Portfolio Pharmaceuticals lost a significant share of the market to other players.
Following that, a lengthy court battle ensued, which had affected supply, with some patients receiving a weekly, rather than their monthly allocations.
Instead, it has sparked a storm of accusations, denials, and unresolved questions about the influence of De Beers on the nation’s politics. Former president Mokgweetsi Masisi’s claims that the diamond giants bankrolled his removal to dodge taxes – and that the new Umbrella for Democratic Change (UDC) government watered down a favourable diamond deal – are explosive matters. But without evidence, they risk becoming a toxic distraction from...